IOZK Veröffentlichungen Archive - Seite 8 von 11 - IOZK

Bispecific antibodies and trispecific immunocytokines for targeting the immune system against cancer: preparing for the future

2013-02-01/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus

Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial

2012-04-22/in Dendritic Cells, Glioblastoma, International Publications, IOZK Veröffentlichungen

Analysis of three properties of Newcastle disease virus for fighting cancer: tumor-selective replication, antitumor cytotoxicity, and immunostimulation

2012-01-01/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus

Newcastle disease virus induces pro-inflammatory conditions and type I interferon for counter-acting Treg activity

2011-11-16/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus

Importance of retinoic acid-inducible gene I and of receptor for type I interferon for cellular resistance to infection by Newcastle disease virus

2011-10-04/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus

Important role of interferon regulatory factor (IRF)-3 in the interferon response of mouse macrophages upon infection by Newcastle disease virus

2011-05-09/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus

Targeting of IL-2 and GM-CSF immunocytokines to a tumor vaccine leads to increased anti-tumor activity

2011-03-17/in Dendritic Cells, International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus

Antitumor vaccination by Newcastle Disease Virus Hemagglutinin-Neuraminidase plasmid DNA application: changes in tumor microenvironment and activation of innate anti-tumor immunity

2010-12-18/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus

Transcriptome analysis and cytokine profiling of naive T cells stimulated by a tumor vaccine via CD3 and CD25

2010-12-01/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus

Optimization studies for the coupling of bispecific antibodies to viral anchor molecules of a tumor vaccine

2010-11-01/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus